These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16944348)

  • 21. [Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis].
    Rovira A; Tintoré M; Alvarez-Cermeño JC; Izquierdo G; Prieto JM
    Neurologia; 2010 May; 25(4):248-65. PubMed ID: 20609303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.
    Rojas JI; Patrucco L; Miguez J; Cristiano E
    Arq Neuropsiquiatr; 2016 Mar; 74(3):235-43. PubMed ID: 27050854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.
    Simon JH
    West J Med; 1996 Jun; 164(6):502-9. PubMed ID: 8764625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline MRI predicts future attacks and disability in clinically isolated syndromes.
    Tintoré M; Rovira A; Río J; Nos C; Grivé E; Téllez N; Pelayo R; Comabella M; Sastre-Garriga J; Montalban X
    Neurology; 2006 Sep; 67(6):968-72. PubMed ID: 17000962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiple sclerosis: the new frontier].
    Confavreux C
    Rev Prat; 2006 Jun; 56(12):1290-2. PubMed ID: 16948215
    [No Abstract]   [Full Text] [Related]  

  • 27. Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis.
    Giorgio A; Portaccio E; Stromillo ML; Marino S; Zipoli V; Battaglini M; Blandino A; Bartolozzi ML; Siracusa G; Amato MP; De Stefano N
    Mult Scler; 2010 Nov; 16(11):1326-34. PubMed ID: 20670979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low degree of cortical pathology is associated with benign course of multiple sclerosis.
    Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P
    Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marburg variant multiple sclerosis - a case report.
    Talab R; Kundrata Z
    Neuro Endocrinol Lett; 2011; 32(4):415-20. PubMed ID: 21876497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Functional magnetic resonance imaging in multiple sclerosis].
    Korsholm K; Mathiesen HK; Lund TE
    Ugeskr Laeger; 2007 Jun; 169(26):2518-20. PubMed ID: 17725897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
    Marques IB; Matias F; Silva ED; Cunha L; Sousa L
    J Clin Neurosci; 2014 Apr; 21(4):583-6. PubMed ID: 24231563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
    Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B
    Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
    Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
    J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sclerosis: what have we learned?
    Karceski S
    Neurology; 2007 Feb; 68(9):E9-10. PubMed ID: 17325266
    [No Abstract]   [Full Text] [Related]  

  • 36. [Magnetic resonance imaging of the brain in multiple sclerosis].
    Kharchenko VP; Krivenko EV; Nikiforuk NM
    Vestn Rentgenol Radiol; 1999; (2):4-8. PubMed ID: 12717894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign multiple sclerosis.
    Thompson AJ
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):138. PubMed ID: 10406975
    [No Abstract]   [Full Text] [Related]  

  • 38. [Magnetic resonance imaging in multiple sclerosis].
    Brochet B; Dousset V
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):1025-32. PubMed ID: 12407314
    [No Abstract]   [Full Text] [Related]  

  • 39. Does race matter for multiple sclerosis?
    Cree B; Waubant E
    Neurology; 2010 Feb; 74(7):532-3. PubMed ID: 20089941
    [No Abstract]   [Full Text] [Related]  

  • 40. Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
    Sweeney EM; Shinohara RT; Dewey BE; Schindler MK; Muschelli J; Reich DS; Crainiceanu CM; Eloyan A
    Neuroimage Clin; 2016; 10():1-17. PubMed ID: 26693397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.